{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:42:20Z","timestamp":1789123340095,"version":"build-2803163510"},"reference-count":32,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Insulin and insulin-like growth factors (IGFs) are mitogenic and prosurvival factors to many different cell types, including acute lymphoblastic leukemia (ALL). Circulating IGFs are bound by IGF binding proteins (IGFBPs) that regulate their action. IGFBP7 is an IGFBP-related protein (IGFBP-rP) that in contrast to other IGFBPs\/IGFBP-rPs features higher affinity for insulin than IGFs and was shown to bind the IGF1 receptor (IGF1R) as well. The role of IGFBP7 in cancer is controversial: on some tumors, it functions as an oncogene, whereas in others, it functions as a tumor suppressor. In childhood ALL, higher IGFBP7 expression levels were associated with worse prognosis. Here we show that IGFBP7 exerts mitogenic and prosurvival autocrine effects on ALL cells that were dependent on insulin\/IGF. IGFBP7 knockdown or antibody-mediated neutralization resulted in significant attenuation of ALL cell viability in vitro and leukemia progression in vivo. IGFBP7 was shown to prolong the surface retention of the IGF1R under insulin\/IGF1 stimulation, resulting in sustained IGF1R, insulin receptor substrate 1 (IRS-1), protein kinase B (AKT), and extracellular signal-regulated kinase (ERK) phosphorylation. Conversely, the insulin receptor was readily internalized and dephosphorylated on insulin stimulation, despite IGFBP7 addition. The affinity of homodimeric IGF1R for insulin is reportedly &amp;gt;100 times lower than for IGF1. In the presence of IGFBP7, however, 25 ng\/mL insulin resulted in IGF1R activation levels equivalent to that of 5 ng\/mL IGF1. In conclusion, IGFBP7 plays an oncogenic role in ALL by promoting the perdurance of IGF1R at the cell surface, prolonging insulin\/IGF stimulation. Preclinical data demonstrate that IGFBP7 is a valid target for antibody-based therapeutic interventions in ALL.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020003627","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T21:57:43Z","timestamp":1630015063000},"page":"3633-3646","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":25,"title":["Physiologic IGFBP7 levels prolong IGF1R activation in acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4691-2446","authenticated-orcid":false,"given":"Leonardo Lu\u00eds","family":"Artico","sequence":"first","affiliation":[{"name":"Centro Infantil Boldrini, Campinas, Brazil;"},{"name":"Graduate Program in Genetics and Molecular Biology, Biology Institute, State University of Capinas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Brunelli Albertoni","family":"Laranjeira","sequence":"additional","affiliation":[{"name":"Centro Infantil Boldrini, Campinas, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia Weijenborg","family":"Campos","sequence":"additional","affiliation":[{"name":"Centro Infantil Boldrini, Campinas, Brazil;"},{"name":"Graduate Program in Genetics and Molecular Biology, Biology Institute, State University of Capinas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1502-0293","authenticated-orcid":false,"given":"Juliana Ronchi","family":"Corr\u00eaa","sequence":"additional","affiliation":[{"name":"Centro Infantil Boldrini, Campinas, Brazil;"},{"name":"Graduate Program in Genetics and Molecular Biology, Biology Institute, State University of Capinas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8662-7458","authenticated-orcid":false,"given":"Priscila Pini","family":"Zenatti","sequence":"additional","affiliation":[{"name":"Centro Infantil Boldrini, Campinas, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0136-0943","authenticated-orcid":false,"given":"Jos\u00e9 Barreto Campello","family":"Carvalheira","sequence":"additional","affiliation":[{"name":"Departamento de Cl\u00ednica M\u00e9dica;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3776-6838","authenticated-orcid":false,"given":"Sandra Regina","family":"Brambilla","sequence":"additional","affiliation":[{"name":"Departamento de Cl\u00ednica M\u00e9dica;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Eduardo","family":"Nowill","sequence":"additional","affiliation":[{"name":"Centro Integrado de Pesquisas Oncohematol\u00f3gicas na Inf\u00e2ncia, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Regina","family":"Brandalise","sequence":"additional","affiliation":[{"name":"Centro Infantil Boldrini, Campinas, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1316-3525","authenticated-orcid":false,"given":"Jos\u00e9 Andr\u00e9s","family":"Yunes","sequence":"additional","affiliation":[{"name":"Centro Infantil Boldrini, Campinas, Brazil;"},{"name":"Departamento de Gen\u00e9tica M\u00e9dica, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"issue":"1","key":"2021092415294309500_B1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10428190210188","article-title":"Survival of B lineage leukemic cells: signals from the bone marrow microenvironment","volume":"43","author":"Gibson","year":"2002","journal-title":"Leuk Lymphoma."},{"issue":"3","key":"2021092415294309500_B2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1210\/edrv.21.3.0399","article-title":"The effects of insulin-like growth factors on tumorigenesis and neoplastic growth","volume":"21","author":"Khandwala","year":"2000","journal-title":"Endocr Rev."},{"issue":"1","key":"2021092415294309500_B3","doi-asserted-by":"crossref","first-page":"T69","DOI":"10.1530\/JME-17-0311","article-title":"IGF1 receptor signaling pathways","volume":"61","author":"Hakuno","year":"2018","journal-title":"J Mol Endocrinol."},{"issue":"1","key":"2021092415294309500_B4","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr Rev."},{"issue":"1","key":"2021092415294309500_B5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12185-012-1234-3","article-title":"Effects of insulin-like growth factor-1 on B-cell precursor acute lymphoblastic leukemia","volume":"97","author":"Yamada","year":"2013","journal-title":"Int J Hematol."},{"issue":"6","key":"2021092415294309500_B6","first-page":"761","article-title":"The insulin-like growth factor-binding protein (IGFBP) superfamily","volume":"20","author":"Hwa","year":"1999","journal-title":"Endocr Rev."},{"issue":"49","key":"2021092415294309500_B7","doi-asserted-by":"crossref","first-page":"30729","DOI":"10.1074\/jbc.272.49.30729","article-title":"Inhibition of insulin receptor activation by insulin-like growth factor binding proteins","volume":"272","author":"Yamanaka","year":"1997","journal-title":"J Biol Chem."},{"issue":"12","key":"2021092415294309500_B8","first-page":"1671","article-title":"Synergistic growth stimulation of mouse fibroblasts by tumor-derived adhesion factor with insulin-like growth factors and insulin","volume":"7","author":"Akaogi","year":"1996","journal-title":"Cell Growth Differ."},{"issue":"5","key":"2021092415294309500_B9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/leu.2011.289","article-title":"IGFBP7 participates in the reciprocal interaction between acute lymphoblastic leukemia and BM stromal cells and in leukemia resistance to asparaginase","volume":"26","author":"Laranjeira","year":"2012","journal-title":"Leukemia."},{"key":"2021092415294309500_B10","first-page":"16","article-title":"Synthetic peptides for production of antibodies that recognize intact proteins","volume":"Chapter 11","author":"Grant","year":"2002","journal-title":"Curr Protoc Mol Biol."},{"issue":"255","key":"2021092415294309500_B11","doi-asserted-by":"crossref","first-page":"ra92","DOI":"10.1126\/scisignal.2003184","article-title":"IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors","volume":"5","author":"Evdokimova","year":"2012","journal-title":"Sci Signal."},{"issue":"8","key":"2021092415294309500_B12","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/leu.2010.130","article-title":"BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia","volume":"24","author":"Heesch","year":"2010","journal-title":"Leukemia."},{"issue":"1","key":"2021092415294309500_B13","doi-asserted-by":"crossref","first-page":"T11","DOI":"10.1530\/JME-17-0254","article-title":"IGF-binding proteins","volume":"61","author":"Bach","year":"2018","journal-title":"J Mol Endocrinol."},{"issue":"3","key":"2021092415294309500_B14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.1991.9.3.394","article-title":"Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts","volume":"9","author":"Estrov","year":"1991","journal-title":"J Clin Oncol."},{"issue":"4","key":"2021092415294309500_B15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0145-2126(86)90075-5","article-title":"Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in-vitro chemosensitivity of haematological malignancies","volume":"10","author":"Bird","year":"1986","journal-title":"Leuk Res."},{"issue":"11","key":"2021092415294309500_B16","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1182\/blood.V76.11.2327.2327","article-title":"In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions","volume":"76","author":"Pieters","year":"1990","journal-title":"Blood."},{"issue":"3","key":"2021092415294309500_B17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4161\/cc.7.3.5357","article-title":"The calcineurin\/NFAT signaling pathway: a novel therapeutic target in leukemia and solid tumors","volume":"7","author":"Medyouf","year":"2008","journal-title":"Cell Cycle."},{"issue":"9","key":"2021092415294309500_B18","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.20110121","article-title":"High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling","volume":"208","author":"Medyouf","year":"2011","journal-title":"J Exp Med."},{"issue":"8","key":"2021092415294309500_B19","doi-asserted-by":"crossref","first-page":"E1016","DOI":"10.1073\/pnas.1520245113","article-title":"Endogenous dendritic cells from the tumor microenvironment support T-ALL growth via IGF1R activation","volume":"113","author":"Triplett","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"issue":"6","key":"2021092415294309500_B20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa033513","article-title":"Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment","volume":"351","author":"Holleman","year":"2004","journal-title":"N Engl J Med."},{"issue":"4","key":"2021092415294309500_B21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/08880018.2011.557852","article-title":"Function and expression of insulin-like growth factor-binding protein 7 (IGFBP7) gene in childhood acute myeloid leukemia","volume":"28","author":"Hu","year":"2011","journal-title":"Pediatr Hematol Oncol."},{"issue":"1","key":"2021092415294309500_B22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1186\/s12885-015-1677-z","article-title":"Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL","volume":"15","author":"Bartram","year":"2015","journal-title":"BMC Cancer."},{"key":"2021092415294309500_B23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/bs.pmbts.2016.04.001","article-title":"When phosphorylation encounters ubiquitination: a balanced perspective on IGF-1R signaling","volume":"141","author":"Girnita","year":"2016","journal-title":"Prog Mol Biol Transl Sci."},{"issue":"3","key":"2021092415294309500_B24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cell.2016.05.074","article-title":"Mitotic checkpoint regulators control insulin signaling and metabolic homeostasis","volume":"166","author":"Choi","year":"2016","journal-title":"Cell."},{"key":"2021092415294309500_B25","doi-asserted-by":"crossref","first-page":"e32893","DOI":"10.7554\/eLife.32893","article-title":"IRS-1 acts as an endocytic regulator of IGF-I receptor to facilitate sustained IGF signaling","volume":"7","author":"Yoneyama","year":"2018","journal-title":"eLife."},{"issue":"7","key":"2021092415294309500_B26","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1210\/jc.2002-021315","article-title":"Generation of anti-insulin-like growth factor-binding protein-related protein 1 (IGFBP-rP1\/MAC25) monoclonal antibodies and immunoassay: quantification of IGFBP-rP1 in human serum and distribution in human fluids and tissues","volume":"88","author":"L\u00f3pez-Bermejo","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021092415294309500_B27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s42255-019-0044-9","article-title":"Liver macrophages regulate systemic metabolism through non-inflammatory factors [corrections published in Nat Metab. 2021;3:287 and Nat Metab. 2019;1;497]","volume":"1","author":"Morgantini","year":"2019","journal-title":"Nat Metab."},{"issue":"6","key":"2021092415294309500_B28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1593\/neo.101590","article-title":"Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy","volume":"13","author":"Davison","year":"2011","journal-title":"Neoplasia."},{"issue":"10","key":"2021092415294309500_B29","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1016\/S0021-9258(18)53187-2","article-title":"Relationship between alpha subunit ligand occupancy and beta subunit autophosphorylation in insulin\/insulin-like growth factor-1 hybrid receptors","volume":"268","author":"Frattali","year":"1993","journal-title":"J Biol Chem."},{"issue":"18","key":"2021092415294309500_B30","doi-asserted-by":"crossref","first-page":"12955","DOI":"10.1016\/S0021-9258(18)42367-8","article-title":"A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity","volume":"267","author":"Soos","year":"1992","journal-title":"J Biol Chem."},{"issue":"1","key":"2021092415294309500_B31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1158\/1078-0432.CCR-11-0998","article-title":"The insulin receptor\/insulin-like growth factor receptor family as a therapeutic target in oncology","volume":"18","author":"Pollak","year":"2012","journal-title":"Clin Cancer Res."},{"issue":"13","key":"2021092415294309500_B32","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1182\/blood-2017-01-764316","article-title":"An Fc-engineered CD19 antibody eradicates MRD in patient-derived MLL-rearranged acute lymphoblastic leukemia xenografts","volume":"130","author":"Schewe","year":"2017","journal-title":"Blood."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/18\/3633\/1823530\/advancesadv2020003627.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/18\/3633\/1823530\/advancesadv2020003627.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T19:38:34Z","timestamp":1632512314000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/18\/3633\/476693\/Physiologic-IGFBP7-levels-prolong-IGF1R-activation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":32,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2021,9,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020003627","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]}}}